117 related articles for article (PubMed ID: 37773687)
1. Clinical Efficacy of Neoadjuvant Chemotherapy plus Modified Radical Mastectomy for Stage II-III Breast Cancer Patients and Its Influence on Serum Tumor Markers.
Yan S; Li J; Chen J; Zhou Y; Qiu Y; Chen Y; Wu W
Altern Ther Health Med; 2024 Jan; 30(1):260-264. PubMed ID: 37773687
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of modified radical mastectomy with nipple-areola preservation combined with stage I prosthesis implantation using air cavity-free suspension hook in patients with breast cancer.
Liu J; Yu H; He Y; Yan T; Ding Y; Chu J; Gao N; Lin X; Xu Y; He G
World J Surg Oncol; 2021 Apr; 19(1):108. PubMed ID: 33838675
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant pertuzumab plus trastuzumab in combination with anthracycline- free chemotherapy regimen in patients with HER2 positive breast cancer-Real-world data from a single center in India.
Arora S; Gogia DA; Deo S; Sharma D; Mathur SR
Cancer Treat Res Commun; 2021; 29():100483. PubMed ID: 34710849
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
[TBL] [Abstract][Full Text] [Related]
5. Breast-conserving surgery versus modified radical mastectomy in treatment of early stage breast cancer: A retrospective study of 107 cases.
Chen Z; Xu Y; Shu J; Xu N
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C29-31. PubMed ID: 26323920
[TBL] [Abstract][Full Text] [Related]
6. [Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer].
Kolyadina IV; Zavalishina LE; Ganshina IP; Andreeva YY; Frank GA; Gordeeva OO; Zhukova LG; Meshcheryakov AA; Savelov NA; Tuzova EA; Morozov DA; Poddubnaya IV
Arkh Patol; 2019; 81(6):56-62. PubMed ID: 31851193
[TBL] [Abstract][Full Text] [Related]
7. The impact of immediate breast reconstruction on post-mastectomy lymphedema in patients undergoing modified radical mastectomy.
Lee KT; Mun GH; Lim SY; Pyon JK; Oh KS; Bang SI
Breast; 2013 Feb; 22(1):53-7. PubMed ID: 22595248
[TBL] [Abstract][Full Text] [Related]
8. Pain and quality of life after surgery for breast cancer.
Caffo O; Amichetti M; Ferro A; Lucenti A; Valduga F; Galligioni E
Breast Cancer Res Treat; 2003 Jul; 80(1):39-48. PubMed ID: 12889597
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Chemotherapy and Nipple-Sparing Mastectomy: Timing and Postoperative Complications.
Bartholomew AJ; Dervishaj OA; Sosin M; Kerivan LT; Tung SS; Caragacianu DL; Willey SC; Tousimis EA
Ann Surg Oncol; 2019 Sep; 26(9):2768-2772. PubMed ID: 31123933
[TBL] [Abstract][Full Text] [Related]
10. Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study.
Yang JR; Kuo WL; Yu CC; Chen SC; Huang JJ
BMC Cancer; 2021 May; 21(1):522. PubMed ID: 33964927
[TBL] [Abstract][Full Text] [Related]
11. Effect of modified radical mastectomy combined with latissimus dorsi musculocutaneous flap breast reconstruction on patients' psychology and quality of life.
Li YJ; Tang XN; Li XQ
Am J Transl Res; 2021; 13(10):11548-11555. PubMed ID: 34786081
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of immediate perforator flap reconstruction after skin-sparing mastectomy following neoadjuvant chemotherapy.
Narui K; Ishikawa T; Satake T; Adachi S; Yamada A; Shimada K; Shimizu D; Kida K; Sugae S; Ichikawa Y; Tanabe M; Sasaki T; Endo I
Eur J Surg Oncol; 2015 Jan; 41(1):94-9. PubMed ID: 25245538
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of risk factors for postoperative wound infection following radical mastectomy in breast cancer patients.
Hu Y; Mao Z; Xu Y
Int Wound J; 2024 Apr; 21(4):e14848. PubMed ID: 38578050
[TBL] [Abstract][Full Text] [Related]
14. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
Tai Q; Shao H; Liu Y; Li E; Zhao R
J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
[TBL] [Abstract][Full Text] [Related]
15. The impact of neoadjuvant chemotherapy on surgical outcomes following autologous and implant-based immediate breast reconstruction: A systematic review and meta-analysis.
Sabitovic A; Trøstrup H; Damsgaard TE
J Plast Reconstr Aesthet Surg; 2023 Dec; 87():17-23. PubMed ID: 37804643
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Neoadjuvant Chemotherapy on Safety Outcomes Following Immediate Breast Reconstruction.
Grigor EJM; Stein MJ; Arnaout A; Ghaedi B; Ramsay T; Zhang J
J Plast Reconstr Aesthet Surg; 2022 Aug; 75(8):2520-2525. PubMed ID: 35396192
[TBL] [Abstract][Full Text] [Related]
17. 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: clinical results and future perspectives with reference to FDG-PET.
Nakamura S; Kenjo H; Nishio T; Kazama T; Do O; Suzuki K
Breast Cancer; 2001; 8(4):351-4. PubMed ID: 11791129
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience.
Zaher HAE; Fathy H; Abozeid M; Faisal M
World J Surg Oncol; 2023 Oct; 21(1):314. PubMed ID: 37805553
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy reduces the levels of HMGB1 and E-cadherin in patients with breast cancer.
Su Q; Wang X; Zhu R; Liu C; Sun S
Sci Rep; 2023 Sep; 13(1):14791. PubMed ID: 37684327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
